Join UCLA gynecologic oncologist Beth Karlan, MD, for an overview of state-of-the-art treatments for ovarian cancer and what’s different about hereditary ovarian cancer. Dr. Karlan will discuss indications for genetic testing, the role of tumor molecular profiling in improving patient survival and new, targeted therapeutic options.